• CD44-Driven Metabolic Rewiring in IDH-Mutant Leukemia: New T

  2026-05-06

  This article reviews recent evidence that CD44-mediated metabolic rewiring is a critical dependency in IDH-mutant acute myeloid leukemia (AML). The reference study uncovers a feedforward pathway sustaining oncometabolite production and highlights new avenues for therapeutic intervention, including combined metabolic and IDH-mutant enzyme inhibition.

• Ziprasidone HCl: Bridging Neuropharmacology and Oncology

  2026-05-05

  This thought-leadership article explores how Ziprasidone Hydrochloride (Ziprasidone HCl) is redefining the translational research landscape by uniting dopaminergic and serotonergic signaling studies with innovative metabolic reprogramming strategies in cancer. We provide mechanistic insight, protocol guidance, and a strategic roadmap for researchers seeking to harness this agent’s unique dual-action profile.

• PPARγ Activation Modulates Macrophage Polarization in IBD Mo

  2026-05-05

  This study demonstrates that activation of PPARγ, including by pioglitazone, regulates macrophage polarization and ameliorates dextran sulfate sodium-induced inflammatory bowel disease by modulating the STAT-1/STAT-6 pathway. These findings clarify molecular mechanisms underlying inflammation resolution and provide a framework for future IBD and immunomodulation research.

• Cdk5-AMPK Axis Modulates Microglial Ferroptosis in Ischemic

  2026-05-04

  This study elucidates how Cdk5 downregulation mitigates neuronal ferroptosis in ischemic stroke models by modulating the AMPK pathway and microglial polarization. The findings highlight actionable targets for neuroprotection and showcase methodological advances relevant for iron metabolism research.

• Ziprasidone Hydrochloride: GOT1 Inhibition & Oncology Benchm

  2026-05-04

  Ziprasidone hydrochloride (Ziprasidone HCl) is a second-generation antipsychotic with validated activity as a GOT1 inhibitor, disrupting tumor glutamine metabolism and inhibiting proliferation in pancreatic cancer models. The compound demonstrates specific in vitro and in vivo benchmarks with clear mechanistic rationale. APExBIO supplies high-purity Ziprasidone HCl (A5350) for advanced translational research.

• HBsAg Exploits TBK1 to Suppress IFN-I and Induce Early Autop

  2026-05-03

  This study uncovers a unique mechanism by which hepatitis B surface antigen (HBsAg) hijacks the kinase TBK1 to suppress type I interferon (IFN-I) responses and induce an early, incomplete autophagy state in hepatocytes. These insights refine our understanding of HBV immune evasion and provide new mechanistic connections between innate immunity and autophagy.

• Protease Inhibitor Cocktail: Redefining Protein Stability in

  2026-05-02

  Explore how the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) uniquely safeguards plant protein integrity, illuminating the interplay between protease inhibition and RNA-based plant immunity. Gain practical insights for advanced molecular assays with this comprehensive analysis.

• Trelagliptin Promotes Osteoblastic Differentiation via RUNX2

  2026-05-02

  This study demonstrates that Trelagliptin, a DPP-4 inhibitor, enhances osteoblastic differentiation in MC3T3-E1 cells by upregulating RUNX2 through an AMPK-dependent pathway. These findings suggest a promising new therapeutic avenue for osteoporosis and inform protocols requiring precise nucleated cell isolation in bone research.

• Lymphodepleting Chemotherapy Enhances T Cell Therapy via Ant

  2026-05-01

  This study demonstrates that lymphodepleting chemotherapy, notably cyclophosphamide and fludarabine, remodels the tumor antigenic landscape and upregulates antigen presentation machinery. The result is a significant improvement in the efficacy of neoantigen-directed adoptive T cell therapy, offering a mechanistic foundation for optimizing immunotherapy regimens in solid tumors.

• Fucoidan: Mechanistic Insights and Translational Strategies

  2026-04-30

  This thought-leadership article dissects the mechanistic basis and translational potential of Fucoidan, a sulfated α-L-fucan, as an anticancer and immune-modulating agent. By integrating recent evidence on caveolin-1 targeting in breast cancer and providing workflow-anchored protocol recommendations, it offers strategic guidance for researchers seeking to leverage high-purity Fucoidan—such as APExBIO’s C4038—in advanced oncology and immunology pipelines.

• Doxorubicin in 3D Cancer Models: Applied Workflows & Optimiz

  2026-04-30

  Doxorubicin (Adriamycin) remains the gold-standard chemotherapeutic agent for dissecting cancer cell death and drug resistance, especially within advanced 3D in vitro models. Explore optimized protocols, troubleshooting guidance, and actionable insights that ensure robust, reproducible results across cancer research applications.

• Stiripentol: Advanced LDH Inhibitor Workflows for Epilepsy a

  2026-04-29

  Stiripentol stands out as a noncompetitive LDH inhibitor, enabling precise modulation of lactate metabolism for both neuroscience and oncology research. This guide details applied workflows, troubleshooting insights, and protocol enhancements that maximize Stiripentol’s utility in dissecting the astrocyte-neuron lactate shuttle and tumor microenvironment.

• PFOS Induces Ferroptosis and ER Stress in Human Kidney Cells

  2026-04-29

  This study provides new mechanistic insights into how perfluorooctane sulfonate (PFOS) causes injury in human proximal tubular epithelial (HK-2) cells via ferroptosis and endoplasmic reticulum (ER) stress pathways. These findings clarify molecular events underlying PFOS nephrotoxicity, informing future research on environmental toxicants and kidney disease.

• Puromycin dihydrochloride: Technical Guidance for Cell Selec

  2026-04-28

  Puromycin dihydrochloride is used for precise selection and maintenance of eukaryotic and prokaryotic cell lines expressing the pac gene, and for probing translation and ribosome function. Its use is optimal in workflows requiring stringent protein synthesis inhibition or selection marker application, but must be carefully titrated to each cell type to avoid nonspecific cytotoxicity.

• Decoding Protein Dynamics: The Science of Triple Color Prest

  2026-04-28

  Explore how the Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) transforms SDS-PAGE and Western blot workflows. This article delves into its scientific design, advanced compatibility, and unique benefits for phosphoprotein and fluorescent imaging assays.

464 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page